China Debates Changes In Government Price Ceilings On Drugs As Part Of Health System Reforms
This article was originally published in PharmAsia News
Executive Summary
BEIJING - As part of sweeping health system reforms that China is charting out for the next decade, the government is now mulling over how to change its price caps on medicines and how to formulate or approve pricing for virtually every drug on the market